An Open-label Study of the Single-dose Pharmacokinetics of Olmesartan Medoxomil in Pediatric Patients With Hypertension.
Phase of Trial: Phase I
Latest Information Update: 14 Aug 2017
At a glance
- Drugs Olmesartan medoxomil (Primary)
- Indications Hypertension
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Daiichi Sankyo Europe
- 09 Apr 2008 Status changed from in progress to completed according to ClinicalTrials.gov.
- 11 Mar 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov.
- 13 Nov 2005 New trial record.